Loading clinical trials...
Loading clinical trials...
An open label, prospective, two-arm, multicenter, randomized controlled trial comparing SakuraBead genicular artery embolization (GAE) with a control (corticosteroid injection).
To compare safety and efficacy of SakuraBead with corticosteroid injection for the treatment of pain secondary to knee osteoarthritis. Treatment will be performed on a total of approximately 89 patients who will be followed up for a period of 2 years.
Age
40 - 79 years
Sex
ALL
Healthy Volunteers
No
University of Alabama Medicine
Birmingham, Alabama, United States
Harbor UCLA Medical Center
Torrance, California, United States
Advanced Vascular Institute
Panama City, Florida, United States
IR Centers
Raleigh, North Carolina, United States
IR Centers
Leesburg, Virginia, United States
Bokhua Memorial Cardiovascular Center
Tbilisi, Georgia
Royal Berkshire NHS Foundation Trust
Reading, United Kingdom
Nano Medical Clinic
Tashkent, Uzbekistan, Uzbekistan
Start Date
November 28, 2024
Primary Completion Date
October 1, 2026
Completion Date
October 1, 2028
Last Updated
March 18, 2026
89
ESTIMATED participants
SakuraBead Resorbable Microspheres
DEVICE
Corticosteroid Injection
DRUG
Lead Sponsor
CrannMed
NCT06243848
NCT05742776
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions